{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T14:09:29Z","timestamp":1793542169250,"version":"4.5.0"},"reference-count":121,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":2877,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s13311-015-0387-1","type":"journal-article","created":{"date-parts":[[2015,9,4]],"date-time":"2015-09-04T09:33:02Z","timestamp":1441359182000},"page":"825-836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":567,"title":["Cannabidiol as a Potential Treatment for Anxiety Disorders"],"prefix":"10.1016","volume":"12","author":[{"given":"Esther M.","family":"Blessing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria M.","family":"Steenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Manzanares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles R.","family":"Marmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-015-0387-1_bib1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.7326\/0003-4819-146-5-200703060-00004","article-title":"Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection","volume":"146","author":"Kroenke","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1007\/s13311-015-0387-1_bib2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0165-0327(01)00354-8","article-title":"Suicide risk in patients with anxiety disorders: a meta-analysis of the FDA database","volume":"68","author":"Khan","year":"2002","journal-title":"J Affect Disord"},{"key":"10.1007\/s13311-015-0387-1_bib3","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.cpr.2007.01.015","article-title":"Quality of life in the anxiety disorders: a meta-analytic review","volume":"27","author":"Olatunji","year":"2007","journal-title":"Clin Psychol Rev"},{"key":"10.1007\/s13311-015-0387-1_bib4","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1007\/s13311-015-0387-1_bib5","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/archpsyc.62.6.629","article-title":"Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication","volume":"62","author":"Wang","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1007\/s13311-015-0387-1_bib6","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.euroneuro.2011.08.008","article-title":"Cost of disorders of the brain in Europe 2010","volume":"21","author":"Gustavsson","year":"2011","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1007\/s13311-015-0387-1_bib7","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1176\/appi.ajp.158.12.1989","article-title":"An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder","volume":"158","author":"Otto","year":"2001","journal-title":"Am J Psychiary"},{"key":"10.1007\/s13311-015-0387-1_bib8","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.4088\/JCP.v65n1216","article-title":"Remission rates in patients with anxiety disorders treated with paroxetine","volume":"65","author":"Ballenger","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1007\/s13311-015-0387-1_bib9","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1001\/jama.2011.1080","article-title":"Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial","volume":"306","author":"Krystal","year":"2011","journal-title":"JAMA"},{"key":"10.1007\/s13311-015-0387-1_bib10","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1176\/appi.ps.201300234","article-title":"Associations of psychotherapy dose and SSRI or SNRI refills with mental health outcomes among veterans with PTSD","volume":"65","author":"Shin","year":"2014","journal-title":"Psychiatr Serv"},{"key":"10.1007\/s13311-015-0387-1_bib11","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.tips.2009.07.006","article-title":"Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb","volume":"30","author":"Izzo","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"10.1007\/s13311-015-0387-1_bib12","first-page":"3364","article-title":"Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders","volume":"367","author":"Campos","year":"2012","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"key":"10.1007\/s13311-015-0387-1_bib13","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/S1516-4446(12)70057-0","article-title":"Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug","volume":"34","author":"Schier","year":"2012","journal-title":"Rev Bras Psiquiatr"},{"key":"10.1007\/s13311-015-0387-1_bib14","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2174\/1871527313666140612114838","article-title":"Antidepressant-like and anxiolytic-like effects of cannabidiol: A chemical compound of Cannabis sativa","volume":"13","author":"Schier","year":"2014","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1007\/s13311-015-0387-1_bib15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pharmthera.2012.12.002","article-title":"Endocannabinoid system and mood disorders: priming a target for new therapies","volume":"138","author":"Micale","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1007\/s13311-015-0387-1_bib16","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/cbdv.200790147","article-title":"Cannabidiol\u2014recent advances","volume":"4","author":"Mechoulam","year":"2007","journal-title":"Chem Biodivers"},{"key":"10.1007\/s13311-015-0387-1_bib17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fnbeh.2011.00063","article-title":"Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects","volume":"5","author":"Marco","year":"2011","journal-title":"Front Behav Neurosci"},{"key":"10.1007\/s13311-015-0387-1_bib18","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/epi.12631","article-title":"Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders","volume":"55","author":"Devinsky","year":"2014","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-015-0387-1_bib19","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.2174\/13816128113199990427","article-title":"Cannabinoids and schizophrenia: therapeutic prospects","volume":"20","author":"Robson","year":"2014","journal-title":"Curr Pharm Design"},{"key":"10.1007\/s13311-015-0387-1_bib20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/157488611798280924","article-title":"Safety and side effects of cannabidiol, a Cannabis sativa constituent","volume":"6","author":"Bergamaschi","year":"2011","journal-title":"Curr Drug Saf"},{"key":"10.1007\/s13311-015-0387-1_bib21","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/bph.12944","article-title":"Are cannabidiol and Delta(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review","volume":"172","author":"McPartland","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-015-0387-1_bib22","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0165-6147(00)01712-0","article-title":"Anandamide: Some like it hot","volume":"22","author":"Di Marzo","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"10.1007\/s13311-015-0387-1_bib23","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1126\/science.1063545","article-title":"Endocannabinoid signaling in the brain","volume":"296","author":"Wilson","year":"2002","journal-title":"Science"},{"key":"10.1007\/s13311-015-0387-1_bib24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fnbeh.2012.00009","article-title":"The endocannabinoid system: An overview","volume":"6","author":"Battista","year":"2012","journal-title":"Front Behav Neurosci"},{"key":"10.1007\/s13311-015-0387-1_bib25","doi-asserted-by":"crossref","first-page":"10039","DOI":"10.1523\/JNEUROSCI.4112-14.2015","article-title":"Multiple forms of endocannabinoid and endovanilloid signaling regulate the tonic control of GABA release","volume":"35","author":"Lee","year":"2015","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-015-0387-1_bib26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.tins.2008.12.006","article-title":"Hot flash: TRPV channels in the brain","volume":"32","author":"Kauer","year":"2009","journal-title":"Trends Neurosci"},{"key":"10.1007\/s13311-015-0387-1_bib27","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.neubiorev.2014.03.026","article-title":"Modulation of defensive behavior by transient receptor potential vanilloid type-1 (TRPV1) channels","volume":"46","author":"Aguiar","year":"2014","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1007\/s13311-015-0387-1_bib28","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.cmet.2013.03.001","article-title":"The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders","volume":"17","author":"Silvestri","year":"2013","journal-title":"Cell Metab"},{"key":"10.1007\/s13311-015-0387-1_bib29","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuron.2012.09.020","article-title":"Endocannabinoid signaling and synaptic function","volume":"76","author":"Castillo","year":"2012","journal-title":"Neuron"},{"key":"10.1007\/s13311-015-0387-1_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neuroscience.2011.11.057","article-title":"Fear relief-toward a new conceptual frame work and what endocannabinoids gotta do with it","volume":"204","author":"Riebe","year":"2012","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-015-0387-1_bib31","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neubiorev.2014.02.006","article-title":"A critical role for prefrontocortical endocannabinoid signaling in the regulation of stress and emotional behavior","volume":"42","author":"McLaughlin","year":"2014","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1007\/s13311-015-0387-1_bib32","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1369-1600.2008.00104.x","article-title":"The endocannabinoid system: emotion, learning and addiction","volume":"13","author":"Moreira","year":"2008","journal-title":"Addict Biol"},{"key":"10.1007\/s13311-015-0387-1_bib33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/0269881111408958","article-title":"The endocannabinoid system in anxiety, fear memory and habituation","volume":"26","author":"Ruehle","year":"2012","journal-title":"J Psychopharmacol"},{"key":"10.1007\/s13311-015-0387-1_bib34","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1007\/s00213-015-3917-y","article-title":"2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons","volume":"232","author":"Llorente-Berzal","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1007\/s13311-015-0387-1_bib35","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nature00839","article-title":"The endogenous cannabinoid system controls extinction of aversive memories","volume":"418","author":"Marsicano","year":"2002","journal-title":"Nature"},{"key":"10.1007\/s13311-015-0387-1_bib36","doi-asserted-by":"crossref","first-page":"6395","DOI":"10.1038\/ncomms7395","article-title":"FAAH genetic variation enhances fronto-amygdala function in mouse and human","volume":"6","author":"Dincheva","year":"2015","journal-title":"Nat Commun"},{"key":"10.1007\/s13311-015-0387-1_bib37","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1523\/JNEUROSCI.2737-14.2015","article-title":"Corticotropin-releasing hormone drives anandamide hydrolysis in the amygdala to promote anxiety","volume":"35","author":"Gray","year":"2015","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-015-0387-1_bib38","doi-asserted-by":"crossref","first-page":"4811","DOI":"10.1210\/en.2010-0285","article-title":"Fast feedback inhibition of the HPA axis by glucocorticoids is mediated by endocannabinoid signaling","volume":"151","author":"Evanson","year":"2010","journal-title":"Endocrinology"},{"key":"10.1007\/s13311-015-0387-1_bib39","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/npp.2013.51","article-title":"Cannabinoids ameliorate impairments induced by chronic stress to synaptic plasticity and short-term memory","volume":"38","author":"Abush","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1007\/s13311-015-0387-1_bib40","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/sj.npp.1300601","article-title":"Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress","volume":"30","author":"Hill","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1007\/s13311-015-0387-1_bib41","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.neuron.2015.02.015","article-title":"Chronic stress induces anxiety via an amygdalar intracellular cascade that impairs endocannabinoid signaling","volume":"85","author":"Qin","year":"2015","journal-title":"Neuron"},{"key":"10.1007\/s13311-015-0387-1_bib42","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/da.22031","article-title":"The endocannabinoid system provides an avenue for evidence-based treatment development for PTSD","volume":"30","author":"Neumeister","year":"2013","journal-title":"Depress Anxiety"},{"key":"10.1007\/s13311-015-0387-1_bib43","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.biopsycho.2014.10.010","article-title":"Toward a translational approach to targeting the endocannabinoid system in posttraumatic stress disorder: a critical review of preclinical research","volume":"104","author":"Papini","year":"2015","journal-title":"Biol Psychol"},{"key":"10.1007\/s13311-015-0387-1_bib44","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1517\/13543784.2015.1020109","article-title":"Investigational drugs under development for the treatment of PTSD","volume":"24","author":"Ragen","year":"2015","journal-title":"Exp Opin Invest Drugs"},{"key":"10.1007\/s13311-015-0387-1_bib45","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.pbb.2005.01.029","article-title":"Endocannabinoid system and stress and anxiety responses","volume":"81","author":"Viveros","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1007\/s13311-015-0387-1_bib46","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/cercor\/bhm161","article-title":"Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex","volume":"18","author":"Rubino","year":"2008","journal-title":"Cereb Cortex"},{"key":"10.1007\/s13311-015-0387-1_bib47","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neuroscience.2011.08.046","article-title":"Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety-two sides of one coin?","volume":"204","author":"Moreira","year":"2012","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-015-0387-1_bib48","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","article-title":"Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide","volume":"134","author":"Bisogno","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-015-0387-1_bib49","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00213-009-1494-7","article-title":"Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats","volume":"204","author":"Haller","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1007\/s13311-015-0387-1_bib50","doi-asserted-by":"crossref","unstructured":"Chessick CA, Allen MH, Thase M, et al. Azapirones for generalized anxiety disorder. Cochrane Database Syst Rev 2006;CD006115.","DOI":"10.1002\/14651858.CD006115"},{"key":"10.1007\/s13311-015-0387-1_bib51","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1177\/0269881113485144","article-title":"Cooperative regulation of anxiety and panic-related defensive behaviors in the rat periaqueductal grey matter by 5-HT1A and mu-receptors","volume":"27","author":"Roncon","year":"2013","journal-title":"J Psychopharmacol"},{"key":"10.1007\/s13311-015-0387-1_bib52","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s00213-013-3350-z","article-title":"Activation of postsynaptic 5-HT1A receptors improve stress adaptation","volume":"231","author":"Zhou","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1007\/s13311-015-0387-1_bib53","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/syn.21621","article-title":"Facilitation of fear extinction by the 5-HT(1A) receptor agonist tandospirone: possible involvement of dopaminergic modulation","volume":"67","author":"Saito","year":"2013","journal-title":"Synapse"},{"key":"10.1007\/s13311-015-0387-1_bib54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/syn.890010103","article-title":"Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists","volume":"1","author":"Sprouse","year":"1987","journal-title":"Synapse"},{"key":"10.1007\/s13311-015-0387-1_bib55","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuropharm.2015.03.007","article-title":"Activation of 5-HT receptors in the medial subdivision of the central nucleus of the amygdala produces anxiolytic effects in a rat model of Parkinson's disease","volume":"95","author":"Sun","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1007\/s13311-015-0387-1_bib56","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s40263-013-0071-0","article-title":"Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research","volume":"27","author":"Celada","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1007\/s13311-015-0387-1_bib57","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11064-005-6978-1","article-title":"Agonistic properties of cannabidiol at 5-HT1a receptors","volume":"30","author":"Russo","year":"2005","journal-title":"Neurochem Res"},{"key":"10.1007\/s13311-015-0387-1_bib58","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1111\/j.1476-5381.2011.01621.x","article-title":"Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus","volume":"165","author":"Rock","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-015-0387-1_bib59","first-page":"25","article-title":"Comparative effects between cannabidiol and diazepam on neophobia, food intake and conflict behavior","volume":"6","author":"Silveira Filho","year":"1981","journal-title":"Res Commun Psychol Psychiatry Behav"},{"key":"10.1007\/s13311-015-0387-1_bib60","first-page":"137","article-title":"Characteristics of the stimulus produced by the mixture of cannabidiol with delta 9-tetrahydrocannabinol","volume":"249","author":"Zuardi","year":"1981","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1007\/s13311-015-0387-1_bib61","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0022-3565(25)13195-9","article-title":"Pharmacological characterization of cannabinoids in the elevated plus maze","volume":"253","author":"Onaivi","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1007\/s13311-015-0387-1_bib62","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.pnpbp.2006.06.004","article-title":"Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test","volume":"30","author":"Moreira","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1007\/s13311-015-0387-1_bib63","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.bbr.2006.05.016","article-title":"Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats","volume":"172","author":"Resstel","year":"2006","journal-title":"Behav Brain Res"},{"key":"10.1007\/s13311-015-0387-1_bib64","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00213-008-1168-x","article-title":"Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats","volume":"199","author":"Campos","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1007\/s13311-015-0387-1_bib65","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.euroneuro.2008.07.001","article-title":"Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats","volume":"18","author":"Bitencourt","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1007\/s13311-015-0387-1_bib66","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.pnpbp.2009.08.017","article-title":"Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids","volume":"33","author":"Campos","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1007\/s13311-015-0387-1_bib67","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1476-5381.2008.00046.x","article-title":"5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats","volume":"156","author":"Resstel","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-015-0387-1_bib68","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bbr.2010.05.004","article-title":"Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors","volume":"213","author":"Soares Vde","year":"2010","journal-title":"Behav Brain Res"},{"key":"10.1007\/s13311-015-0387-1_bib69","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1017\/S1461145709990605","article-title":"A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL\/6JArc mice","volume":"13","author":"Long","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1007\/s13311-015-0387-1_bib70","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbr.2009.09.045","article-title":"Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats","volume":"207","author":"Lemos","year":"2010","journal-title":"Behav Brain Res"},{"key":"10.1007\/s13311-015-0387-1_bib71","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/FBP.0b013e32833b33c5","article-title":"Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors","volume":"21","author":"Casarotto","year":"2010","journal-title":"Behav Pharmacol"},{"key":"10.1007\/s13311-015-0387-1_bib72","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00213-010-2036-z","article-title":"The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors","volume":"213","author":"Gomes","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1007\/s13311-015-0387-1_bib73","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.pbb.2011.06.027","article-title":"Effects of intracisternal administration of cannabidiol on the cardiovascular and behavioral responses to acute restraint stress","volume":"99","author":"Granjeiro","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1007\/s13311-015-0387-1_bib74","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00213-011-2415-0","volume":"219","author":"Deiana","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1007\/s13311-015-0387-1_bib75","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/npp.2011.188","article-title":"Anti-aversive effects of cannabidiol on innate fear-induced behaviors evoked by an ethological model of panic attacks based on a prey vs the wild snake Epicrates cenchria crassus confrontation paradigm","volume":"37","author":"Uribe-Marino","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1007\/s13311-015-0387-1_bib76","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1038\/npp.2012.63","article-title":"On disruption of fear memory by reconsolidation blockade: evidence from cannabidiol treatment","volume":"37","author":"Stern","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1007\/s13311-015-0387-1_bib77","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.jpsychires.2012.08.012","article-title":"Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: possible involvement of 5HT1A receptors","volume":"46","author":"Campos","year":"2012","journal-title":"J Psychiatr Res"},{"key":"10.1007\/s13311-015-0387-1_bib78","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.neuropharm.2011.08.013","article-title":"Effect of cannabidiol on sleep disruption induced by the repeated combination tests consisting of open field and elevated plus-maze in rats","volume":"62","author":"Hsiao","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1007\/s13311-015-0387-1_bib79","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/0269881110389095","article-title":"Cannabidiol injected into the bed nucleus of the stria terminalis reduces the expression of contextual fear conditioning via 5-HT1A receptors","volume":"26","author":"Gomes","year":"2012","journal-title":"J Psychopharmacol"},{"key":"10.1007\/s13311-015-0387-1_bib80","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00213-011-2566-z","article-title":"Anxiogenic-like effects of chronic cannabidiol administration in rats","volume":"221","author":"El Batsh","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1007\/s13311-015-0387-1_bib81","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1017\/S1461145712001502","article-title":"The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system","volume":"16","author":"Campos","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1007\/s13311-015-0387-1_bib82","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bbr.2013.04.045","article-title":"Infusion of cannabidiol into infralimbic cortex facilitates fear extinction via CB1 receptors","volume":"250","author":"Do Monte","year":"2013","journal-title":"Behav Brain Res"},{"key":"10.1007\/s13311-015-0387-1_bib83","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00213-012-2878-7","article-title":"Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats","volume":"226","author":"Campos","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1007\/s13311-015-0387-1_bib84","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pnpbp.2012.10.024","article-title":"Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test","volume":"41","author":"Almeida","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1007\/s13311-015-0387-1_bib85","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.euroneuro.2012.09.007","article-title":"Cannabidiol administration into the bed nucleus of the stria terminalis alters cardiovascular responses induced by acute restraint stress through 5-HT(1)A receptor","volume":"23","author":"Gomes","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1007\/s13311-015-0387-1_bib86","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1177\/0269881113493363","article-title":"The role of 5-HT1A receptors in the anti-aversive effects of cannabidiol on panic attack-like behaviors evoked in the presence of the wild snake Epicrates cenchria crassus (Reptilia, Boidae)","volume":"27","author":"Twardowschy","year":"2013","journal-title":"J Psychopharmacol"},{"key":"10.1007\/s13311-015-0387-1_bib87","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.euroneuro.2013.10.012","article-title":"Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: involvement of 5HT1A receptors and previous stressful experience","volume":"24","author":"Fogaca","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1007\/s13311-015-0387-1_bib88","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/fcp.12051","article-title":"Cannabidiol reverses the mCPP-induced increase in marble-burying behavior","volume":"28","author":"Nardo","year":"2014","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1007\/s13311-015-0387-1_bib89","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejphar.2015.03.051","volume":"758","author":"da Silva","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1007\/s13311-015-0387-1_bib90","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/BF02244012","article-title":"Antianxiety effect of cannabidiol in the elevated plus-maze","volume":"100","author":"Guimaraes","year":"1990","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1007\/s13311-015-0387-1_bib91","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0166-2236(94)90047-7","article-title":"Columnar organization in the midbrain periaqueductal gray: modules for emotional expression?","volume":"17","author":"Bandler","year":"1994","journal-title":"Trends Neurosci"},{"key":"10.1007\/s13311-015-0387-1_bib92","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3171\/jns.1969.30.1.0014","article-title":"Sensations evoked by stimulation in the midbrain of man","volume":"30","author":"Nashold","year":"1969","journal-title":"J Neurosurg"},{"key":"10.1007\/s13311-015-0387-1_bib93","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.pnpbp.2009.06.022","article-title":"Selective participation of the bed nucleus of the stria terminalis and CRF in sustained anxiety-like versus phasic fear-like responses","volume":"33","author":"Walker","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1007\/s13311-015-0387-1_bib94","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/npp.2010.184","article-title":"Dissociable roles of prelimbic and infralimbic cortices, ventral hippocampus, and basolateral amygdala in the expression and extinction of conditioned fear","volume":"36","author":"Sierra-Mercado","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1007\/s13311-015-0387-1_bib95","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0149-7634(01)00060-4","article-title":"Modeling panic attacks","volume":"25","author":"Schenberg","year":"2001","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1007\/s13311-015-0387-1_bib96","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00213-009-1466-y","article-title":"Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety","volume":"204","author":"Thomas","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1007\/s13311-015-0387-1_bib97","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.1523\/JNEUROSCI.5491-03.2004","article-title":"Memory reconsolidation and extinction have distinct temporal and biochemical signatures","volume":"24","author":"Suzuki","year":"2004","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-015-0387-1_bib98","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00432554","article-title":"Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects","volume":"76","author":"Zuardi","year":"1982","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1007\/s13311-015-0387-1_bib99","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0014-2999(74)90129-0","article-title":"Cannabidiol interferes with the effects of delta 9 - tetrahydrocannabinol in man","volume":"28","author":"Karniol","year":"1974","journal-title":"Eur J Pharmacol"},{"key":"10.1007\/s13311-015-0387-1_bib100","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/026988119300700112","article-title":"Effects of ipsapirone and cannabidiol on human experimental anxiety","volume":"7","author":"Zuardi","year":"1993","journal-title":"J Psychopharmacol"},{"key":"10.1007\/s13311-015-0387-1_bib101","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.2174\/138161212802884780","article-title":"Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers","volume":"18","author":"Martin-Santos","year":"2012","journal-title":"Curr Pharm Design"},{"key":"10.1007\/s13311-015-0387-1_bib102","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.npp.1300340","article-title":"Effects of cannabidiol (CBD) on regional cerebral blood flow","volume":"29","author":"Crippa","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1007\/s13311-015-0387-1_bib103","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/npp.2009.184","article-title":"Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology","volume":"35","author":"Bhattacharyya","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1007\/s13311-015-0387-1_bib104","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/0269881110379283","article-title":"Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report","volume":"25","author":"Crippa","year":"2011","journal-title":"J Psychopharmacol"},{"key":"10.1007\/s13311-015-0387-1_bib105","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients","volume":"36","author":"Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1007\/s13311-015-0387-1_bib106","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00213-012-2955-y","article-title":"Cannabidiol enhances consolidation of explicit fear extinction in humans","volume":"226","author":"Das","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1007\/s13311-015-0387-1_bib107","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.euroneuro.2014.11.014","article-title":"Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users","volume":"25","author":"Hindocha","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1007\/s13311-015-0387-1_bib108","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.biopsych.2008.05.011","article-title":"Neural basis of Delta-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition","volume":"64","author":"Borgwardt","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1007\/s13311-015-0387-1_bib109","doi-asserted-by":"crossref","unstructured":"Fusar-Poli P, Crippa JA, Bhattacharyya S. Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing. Arch Gen Psychiatry 2009;66:95-105.","DOI":"10.1001\/archgenpsychiatry.2008.519"},{"key":"10.1007\/s13311-015-0387-1_bib110","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1017\/S1461145709990617","article-title":"Modulation of effective connectivity during emotional processing by Delta 9-tetrahydrocannabinol and cannabidiol","volume":"13","author":"Fusar-Poli","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1007\/s13311-015-0387-1_bib111","doi-asserted-by":"crossref","unstructured":"Rubia K, Russell T, Overmeyer S, et al. Mapping motor inhibition: conjunctive brain activations across different versions of go\/no-go and stop tasks. Neuroimage 2001;13:250-261.","DOI":"10.1006\/nimg.2000.0685"},{"key":"10.1007\/s13311-015-0387-1_bib112","doi-asserted-by":"crossref","first-page":"895","DOI":"10.4088\/JCP.12m08020","article-title":"Inhibitory neural activity predicts response to cognitive-behavioral therapy for posttraumatic stress disorder","volume":"74","author":"Falconer","year":"2013","journal-title":"J Clin Psychiatry"},{"key":"10.1007\/s13311-015-0387-1_bib113","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jad.2014.06.041","article-title":"A systematic review of fMRI studies in generalized anxiety disorder: evaluating its neural and cognitive basis","volume":"167","author":"Mochcovitch","year":"2014","journal-title":"J Affect Disord"},{"key":"10.1007\/s13311-015-0387-1_bib114","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.neubiorev.2012.06.003","article-title":"Neurocircuitry models of posttraumatic stress disorder and beyond: a meta-analysis of functional neuroimaging studies","volume":"36","author":"Patel","year":"2012","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1007\/s13311-015-0387-1_bib115","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1038\/npp.2010.58","article-title":"Cannabidiol attenuates the appetitive effects of Delta 9-tetrahydrocannabinol in humans smoking their chosen cannabis","volume":"35","author":"Morgan","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1007\/s13311-015-0387-1_bib116","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1192\/bjp.bp.107.046649","article-title":"Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis","volume":"192","author":"Morgan","year":"2008","journal-title":"Br J Psychiatry"},{"key":"10.1007\/s13311-015-0387-1_bib117","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1192\/bjp.bp.110.077503","article-title":"Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study [corrected]","volume":"197","author":"Morgan","year":"2010","journal-title":"Br J Psychiatry"},{"key":"10.1007\/s13311-015-0387-1_bib118","first-page":"242","article-title":"Diminished gray matter in the hippocampus of cannabis users: possible protective effects of cannabidiol","volume":"114","author":"Demirakca","year":"2011","journal-title":"Drug Alcohol Depend"},{"key":"10.1007\/s13311-015-0387-1_bib119","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fpsyt.2013.00130","article-title":"Does cannabidiol protect against adverse psychological effects of THC?","volume":"4","author":"Niesink","year":"2013","journal-title":"Front Psychiatry"},{"key":"10.1007\/s13311-015-0387-1_bib120","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/02791072.2013.873843","article-title":"PTSD symptom reports of patients evaluated for the New Mexico Medical Cannabis Program","volume":"46","author":"Greer","year":"2014","journal-title":"J Psychoactive Drugs"},{"key":"10.1007\/s13311-015-0387-1_bib121","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/dta.1377","article-title":"Mitigation of post-traumatic stress symptoms by Cannabis resin: a review of the clinical and neurobiological evidence","volume":"4","author":"Passie","year":"2012","journal-title":"Drug Test Anal"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-015-0387-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-015-0387-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923008140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923008140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-015-0387-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:41:58Z","timestamp":1761806518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923008140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":121,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S1878747923008140"],"URL":"https:\/\/doi.org\/10.1007\/s13311-015-0387-1","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabidiol as a Potential Treatment for Anxiety Disorders","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-015-0387-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}